Dyne Therapeutics

DYNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.902 B

$26.25 +1.43%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$446.20

Loss-making

Shares outstanding

186,746,431

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#58GrifolsGRFS$5.46B
#59Acadia PharmaceuticalsACAD$5.03B
#60Dyne TherapeuticsDYN$4.90B
#61Indivior PharmaceuticalsINDV$4.84B
#62VeradermicsMANE$4.78B

Where these numbers come from

Share counts and financials for Dyne Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.